Enhancement updates provide short alerts to new, fixed or improved Connect Care functions...
- Upcoming Formulary Changes
As of February 25, 2025, the below formulary changes will go into effect. Due to these changes, personalizations of the replaced medications within order sets will be removed.
- New topical anesthetic: Lidocaine 4% cream (Maxilene) and prilocaine–lidocaine 2.5 %-2.5% cream (EMLA) will be replaced with lidocaine 5% cream (Zensa). This product is intended to provide topical anesthesia prior to IV cannulation, venipuncture and IM administration. The cost savings identified by this change is significant.
- New oral histamine H2-antagonist: Oral ranitidine (Zantac) will be replaced with oral famotidine (Pepcid).
For further details, see the "DTC Update" newsletter from the Provincial Drugs and Therapeutics Committee (DTC).